These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6955014)

  • 1. Prognostic factors in response to anthracyclines.
    McCredie KB; Keating MJ; Bodey GP; Gehan EA; Smith T; Freireich EJ
    Cancer Treat Rep; 1981; 65 Suppl 4():83-6. PubMed ID: 6955014
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chemotherapeutic approach to acute myeloid leukemia in adults].
    Biron GL; Lapointe Y; Clément S; Maheu M; Laurin S; Gosselin BY
    Union Med Can; 1983 May; 112(5):412-4. PubMed ID: 6576502
    [No Abstract]   [Full Text] [Related]  

  • 3. Anthracyclines in the treatment of acute nonlymphocytic leukemias.
    Boiron M; Jacquillat C; Marty M; Weil M; Gisselbrecht C
    Cancer Treat Rep; 1981; 65 Suppl 4():73-6. PubMed ID: 6955013
    [No Abstract]   [Full Text] [Related]  

  • 4. Improved prospects for long-term survival in adults with acute myelogenous leukemia.
    Keating MJ; McCredie KB; Bodey GP; Smith TL; Gehan E; Freireich EJ
    JAMA; 1982 Nov; 248(19):2481-6. PubMed ID: 6957624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Research on optimal dosage schemes in clinical experimentation with antineoplastic agents].
    Praga C
    Boll Chim Farm; 1972 Feb; 111(2):93-9. PubMed ID: 4505372
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia].
    Takahashi I; Hara M; Ohmoto E; Oda Y; Endo Y; Fujimoto S; Uchida K; Takaoka K; Watanabe S; Lai M; Kohi F; Kitajima K; Kimura I; Sanada H; Tokioka M; Adachi T; Yorimitsu S
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1617-22. PubMed ID: 6964050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical observations of 30 patients with acute promyelocytic leukemia].
    Chang CS; Chen JR; Lin SF; Liu HW; Yen JH
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1986 Oct; 2(10):608-15. PubMed ID: 3330141
    [No Abstract]   [Full Text] [Related]  

  • 8. [Remission induction by ACM-A and BH-AC on acute promyelocytic leukemia which is resistant to DNR and CA (author's transl)].
    Shimazaki C; Nakajima Y; Ura Y; Hamami T; Haruyama H; Isemura T; Nakagawa M; Ijichi H
    Rinsho Ketsueki; 1981 Jul; 22(7):1116-22. PubMed ID: 6948970
    [No Abstract]   [Full Text] [Related]  

  • 9. [Childhood acute myeloblastic leukemias. Report of 21 cases].
    Laatiri MA; Chehata S; Amouri A; Bouaouina N; Chatti S; Saad A; Ennabli S
    Tunis Med; 2000 Mar; 78(3):167-71. PubMed ID: 11026819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective randomized trial of KRN8602 and cytosine arabinoside vs. daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia. The KRN8602 Leukemia Study Group.
    Takemoto Y; Sampi K; Kuraishi Y; Okabe K; Tamura K; Mizoguchi H; Saito H; Masaoka T; Ogawa M
    Int J Hematol; 1999 Jul; 70(1):20-5. PubMed ID: 10446490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New agents in the treatment of leukemia and lymphoma].
    Yamada K
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1031-40. PubMed ID: 6347079
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapy of secondary acute nonlymphocytic leukemia.
    Beltran G; Stuckey WJ
    N Engl J Med; 1983 May; 308(21):1295-6. PubMed ID: 6573569
    [No Abstract]   [Full Text] [Related]  

  • 13. Acyclovir bioavailability in patients with acute myelogenous leukemia treated with daunorubicin and cytarabine.
    Sitar DS; Aoki FY; Bow EJ
    J Clin Pharmacol; 2008 Aug; 48(8):995-8. PubMed ID: 18495946
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of acute myelogenous leukemia in older patients.
    Foon KA; Zighelboim J; Gale RP
    N Engl J Med; 1981 Dec; 305(24):1470. PubMed ID: 6946284
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute myeloblastic leukemia in adults.
    Kasthuri AS; Jaiprakash MP; Anand KP; Kumar R
    J Assoc Physicians India; 1995 Feb; 43(2):108-10. PubMed ID: 9282674
    [No Abstract]   [Full Text] [Related]  

  • 16. [Acute myeloblastic leukemia in adults: evaluation of the AML 06/96 protocol].
    Qachouh M; Quessar A; Harif M; Benchekroun S
    Tunis Med; 2003 Jul; 81(7):461-5. PubMed ID: 14534956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: a study by the German Acute Myeloid Leukemia Cooperative Group.
    Büchner T; Berdel WE; Haferlach C; Haferlach T; Schnittger S; Müller-Tidow C; Braess J; Spiekermann K; Kienast J; Staib P; Grüneisen A; Kern W; Reichle A; Maschmeyer G; Aul C; Lengfelder E; Sauerland MC; Heinecke A; Wörmann B; Hiddemann W
    J Clin Oncol; 2009 Jan; 27(1):61-9. PubMed ID: 19047294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of primary acute myeloid leukemia: results of a prospective multicenter trial including high-dose cytarabine or stem cell transplantation as post-remission strategy.
    Brunet S; Esteve J; Berlanga J; Ribera JM; Bueno J; Martí JM; Bargay J; Guardia R; Juliá A; Granena A; Montserrat E; Sierra J;
    Haematologica; 2004 Aug; 89(8):940-9. PubMed ID: 15339677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
    Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relapse and death during first remission in acute myeloid leukemia.
    Yanada M; Garcia-Manero G; Borthakur G; Ravandi F; Kantarjian H; Estey E
    Haematologica; 2008 Apr; 93(4):633-4. PubMed ID: 18379012
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.